Seagrass provides blue carbon reserve
05 September, 2013As well as being a favourite feeding ground for dugongs and sea turtles, seagrass meadows may be a major carbon sink for the planet.
2013 Eureka Prize winners
05 September, 2013From diamonds that light up the inside of cells to broody male weedy sea dragons, this year's Australian Museum Eureka Prizes recognise some of the great work and great people in Australian science.
Coridon's herpes vaccine trial progressing well
05 September, 2013 by Dylan Bushell-EmblingCoridon, Allied Healthcare's (ASX:AHZ) 50.1%-owned subsidiary, said no safety issues were raised during dosing of the first two cohorts in a phase I study of its herpes vaccine and treatment.
Clinuvel posts follow-up data from vitiligo trial
02 September, 2013 by Dylan Bushell-EmblingDuring a recent trial, Clinuvel's Scenesse (ASX:CUV) was able to improve repigmentation in patients undergoing NB-UVB therapy for vitiligo, and to help sustain the effect.
Measuring brain volume loss
30 August, 2013 by Susan WilliamsonThe Sydney Neuroimaging Analysis Centre, located with the Brain and Mind Research Institute in Sydney, is now home to some sophisticated neuroimaging technology previously unavailable in Australia.
Recognising women in science
28 August, 2013Three early-career scientists have been awarded $25,000 one-year fellowships.
BioDiem wins third US patent for BDM-I
26 August, 2013 by Dylan Bushell-EmblingBioDiem (ASX:BDM) will be granted a US divisional patent covering the use of BDM-I in skin and wound infections caused by different fungi and bacteria.
ReCell vitiligo trial hits recruitment goal
22 August, 2013 by Dylan Bushell-EmblingA clinical trial involving using Avita Medical’s (ASX:AVH) ReCell Spray-on Skin to treat skin pigment disorders has hit its 10-patient recruitment goal.
Industry invests in university Chair
22 August, 2013A new research Chair at the ANU will be funded by Sirtex Medical.
Alchemia earns record fondaparinux profit in Q4
20 August, 2013 by Dylan Bushell-EmblingAlchemia (ASX:ACL) said sales of its generic fondaparinux anticoagulant recovered in the June quarter to reach record levels.
Overlooked cytokine potential anticancer agent
15 August, 2013Interleukin-11 has revealed itself to be a potential new target for anticancer therapies.
Research into precision agriculture recognised
13 August, 2013The 2014 winner of what is widely regarded as the Nobel prize for soil science, the Dokuchaev award, is an Australian researcher.
Endangered species choke on plastic
12 August, 2013When a plastic bag floats in the ocean it looks like a jellyfish, especially to a hungry turtle swimming by.
Breakthrough into the construction of vitamin B12
09 August, 2013Bioscientists at the University of Kent have revealed for the first time how vitamin B12/antipernicious anaemia factor is made. The mystery of its construction is often referred to as “the Mount Everest of biosynthetic problems”.
AmpliPhi presents CF lung data at phage summit
09 August, 2013 by Dylan Bushell-EmblingAmpliPhi BioSciences has used the Evergreen International Phage Meeting to present data supporting the effectiveness of bacteriophage treatments in P. aeruginosa infections.
